C163H159ClF5N25O23S6 — CID 159714007
[4-[(3-chloro-4-pyridinyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;2-cyclohexylethyl 4-[3-methyl-4-(quinolin-8-ylsulfonylamino)benzoyl]piperazine-1-carboxylate;N-[2-fluoro-4-[4-(pyridine-2-carbonyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[2-fluoro-4-[4-(pyridine-3-carbonyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;[4-(oxolan-3-ylmethyl)piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-(quinolin-8-ylsulfonylmethyl)phenyl]-[4-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperazin-1-yl]methanone (PubChem CID 159714007) has the molecular formula C163H159ClF5N25O23S6 and a molecular weight of 3159.06 g/mol. Its IUPAC name is [4-[(3-chloro-4-pyridinyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;2-cyclohexylethyl 4-[3-methyl-4-(quinolin-8-ylsulfonylamino)benzoyl]piperazine-1-carboxylate;N-[2-fluoro-4-[4-(pyridine-2-carbonyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[2-fluoro-4-[4-(pyridine-3-carbonyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;[4-(oxolan-3-ylmethyl)piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-(quinolin-8-ylsulfonylmethyl)phenyl]-[4-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperazin-1-yl]methanone.
| Compound Name | [4-[(3-chloro-4-pyridinyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;2-cyclohexylethyl 4-[3-methyl-4-(quinolin-8-ylsulfonylamino)benzoyl]piperazine-1-carboxylate;N-[2-fluoro-4-[4-(pyridine-2-carbonyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[2-fluoro-4-[4-(pyridine-3-carbonyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;[4-(oxolan-3-ylmethyl)piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-(quinolin-8-ylsulfonylmethyl)phenyl]-[4-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperazin-1-yl]methanone |
|---|---|
| PubChem CID | 159714007 |
| Molecular Formula | C163H159ClF5N25O23S6 |
| Molecular Weight | 3159.06 g/mol |
| Exact Mass | 3156.00 |
| IUPAC Name | [4-[(3-chloro-4-pyridinyl)methyl]piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;2-cyclohexylethyl 4-[3-methyl-4-(quinolin-8-ylsulfonylamino)benzoyl]piperazine-1-carboxylate;N-[2-fluoro-4-[4-(pyridine-2-carbonyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;N-[2-fluoro-4-[4-(pyridine-3-carbonyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide;[4-(oxolan-3-ylmethyl)piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-(quinolin-8-ylsulfonylmethyl)phenyl]-[4-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperazin-1-yl]methanone |
| SMILES | Cc1cc(C(=O)N2CCN(C(=O)OCCC3CCCCC3)CC2)ccc1NS(=O)(=O)c1cccc2cccnc12.O=C(c1ccc(CS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(CC2CCOC2)CC1.O=C(c1ccc(CS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(Cc2ccc(C(F)(F)F)cn2)CC1.O=C(c1ccc(CS(=O)(=O)c2cccc3cccnc23)cc1)N1CCN(Cc2ccncc2Cl)CC1.O=C(c1ccc(NS(=O)(=O)c2cccc3cccnc23)c(F)c1)N1CCN(C(=O)c2ccccn2)CC1.O=C(c1cccnc1)N1CCN(C(=O)c2ccc(NS(=O)(=O)c3cccc4cccnc34)c(F)c2)CC1 |
| InChI | InChI=1S/C30H36N4O5S.C28H25F3N4O3S.C27H25ClN4O3S.2C26H22FN5O4S.C26H29N3O4S/c1-22-21-25(12-13-26(22)32-40(37,38)27-11-5-9-24-10-6-15-31-28(24)27)29(35)33-16-18-34(19-17-33)30(36)39-20-14-23-7-3-2-4-8-23;29-28(30,31)23-10-11-24(33-17-23)18-34-13-15-35(16-14-34)27(36)22-8-6-20(7-9-22)19-39(37,38)25-5-1-3-21-4-2-12-32-26(21)25;28-24-17-29-12-10-23(24)18-31-13-15-32(16-14-31)27(33)22-8-6-20(7-9-22)19-36(34,35)25-5-1-3-21-4-2-11-30-26(21)25;27-21-16-19(25(33)31-12-14-32(15-13-31)26(34)20-6-2-10-28-17-20)8-9-22(21)30-37(35,36)23-7-1-4-18-5-3-11-29-24(18)23;27-20-17-19(25(33)31-13-15-32(16-14-31)26(34)22-7-1-2-11-28-22)9-10-21(20)30-37(35,36)23-8-3-5-18-6-4-12-29-24(18)23;30-26(29-14-12-28(13-15-29)17-21-10-16-33-18-21)23-8-6-20(7-9-23)19-34(31,32)24-5-1-3-22-4-2-11-27-25(22)24/h5-6,9-13,15,21,23,32H,2-4,7-8,14,16-20H2,1H3;1-12,17H,13-16,18-19H2;1-12,17H,13-16,18-19H2;1-11,16-17,30H,12-15H2;1-12,17,30H,13-16H2;1-9,11,21H,10,12-19H2 |
| InChIKey | MZESRQCLPMITAK-UHFFFAOYSA-N |
| XLogP | 23.34 |
| TPSA | 580.80 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 223 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3159.06 |
| LogP ≤ 5 | 23.34 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 36 |